Oprozomib T6041
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Oprozomib (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome _5_IC50=36 nM_/LMP7_IC50=82 nM_, is orally bioavailable. Oprozomib also has potential antineoplastic activity.
CAS nr:
935888-69-0
Purity:
98%
Molecular Weight:
532,61
SMILES:
s1c(ncc1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)[C@@]1(OC1)C)Cc1ccccc1)COC)COC)C
Formula:
C25H32N4O7S
Pathway:
Proteases/Proteasome,Ubiquitination,Autophagy
Target:
Proteasome,Proteasome,Autophagy
